NCT03921996 2023-03-09
Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer
Swiss Cancer Institute
Phase 3 Terminated
Swiss Cancer Institute
Marker Therapeutics, Inc.
Merck KGaA, Darmstadt, Germany
Bayer